Skip to main
DOC
DOC logo

DOC Stock Forecast & Price Target

DOC Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 9%
Buy 55%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Healthpeak Properties boasts a diversified healthcare portfolio comprising approximately 700 properties, predominantly focused on medical office and life science assets, which positions it well within the growing healthcare sector. The company’s strategy includes expanding its medical office building (MOB) portfolio through recent development starts totaling $148 million, offering high certainty of execution and projected stabilized yields in the mid-7% range, with about 80% of the space already pre-leased. These factors contribute to a positive financial outlook, driven by a strong demand for healthcare facilities and potential revenue growth from strategic expansions.

Bears say

Healthpeak Properties faces a negative outlook due to increased credit risk associated with lab tenants, which has led to a reduction in the applied P/AFFOPS multiple and overall earnings forecasts for 2026. The company has experienced weak leasing performance in Q2, prompting a downgrade in projections to a compound annual growth rate (CAGR) of +1%/-1% for FFOPS/AFFOPS from a previous outlook of +2%/+1%. Additionally, management has acknowledged potential headwinds to lab occupancy in the second half of 2025 stemming from challenges in capital raising, further contributing to uncertainty in the company's financial stability.

DOC has been analyzed by 11 analysts, with a consensus rating of Buy. 9% of analysts recommend a Strong Buy, 55% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthpeak Properties Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthpeak Properties Inc (DOC) Forecast

Analysts have given DOC a Buy based on their latest research and market trends.

According to 11 analysts, DOC has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $20.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $20.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthpeak Properties Inc (DOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.